JAMA Clinical Reviews

Diagnosis and Treatment of Systemic Lupus Erythematosus

04.08.2024 - By JAMA NetworkPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Systemic lupus erythematosus (SLE) can present at any age and is associated with immune-mediated damage to multiple organs and increased rates of cardiovascular disease, cancer, and disability. New treatments have been FDA approved. Caroline H. Siegel, MD, MS, discusses this and more with JAMA Deputy Editor Mary McGrae McDermott, MD. Related Content: Systemic Lupus Erythematosus

More episodes from JAMA Clinical Reviews